JWJG-medicated serum significantly suppresses the expression of Nod-like receptor pyrin domain-containing 3(NLRP3) and caspase in RA synovial fibroblasts (SF), inhibiting the maturation of IL-1β and IL-18, mitigating pyroptosis (162). Here, NLRP3 is linked to rheumatoid arthritis.